Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Opus Genetics (IRD) Interest & Investment Income (2020)

Opus Genetics has reported Interest & Investment Income over the past 6 years, most recently at $1774.0 for Q3 2020.

  • Quarterly Interest & Investment Income changed N/A to $1774.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $77098.0 through Sep 2020, changed N/A year-over-year, with the annual reading at $313700.0 for FY2019, 23.34% up from the prior year.
  • Interest & Investment Income was $1774.0 for Q3 2020 at Opus Genetics, down from $6042.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $34418.0 in Q1 2020 and troughed at $1774.0 in Q3 2020.